Latest news

Thumbnail image for US nod for Akcea/Ionis’ Tegsedi

US nod for Akcea/Ionis’ Tegsedi

Akcea and Ionis’ Tegsedi has won US approval for patients with hereditary transthyretin amyloidosis (hATTR), a rare disease causing build up of amyloid in the peripheral nervous system and multiple organs.

8th October 2018

Thumbnail image for Demonstrate your skills and expertise

Demonstrate your skills and expertise

The highly anticipated Medical & Scientific Excellence Awards close for entry in just a few weeks (31 October). This is your chance to stand out against the competition, enter now to get the recognition you deserve.

5th October 2018

Thumbnail image for PRIME status for Orchard’s gene therapy

PRIME status for Orchard’s gene therapy

The European Medicines Agency has granted Orchard Therapeutics’ experimental gene therapy OTL-300 PRIME designation as a potential treatment for the most severe form of beta-thalassemia.

5th October 2018

Thumbnail image for Roche unveils PhIII data for flu drug

Roche unveils PhIII data for flu drug

Roche has unveiled late-stage data showing that its experimental antivrial drug baloxavir marboxil hit efficacy and safety targets in patients with flu.

4th October 2018

Previous  --   1 2 3 4 5 6 7 8 9 10   --  Next

Latest jobs

View all

Download our apps

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Download